Search

everythinglearnresearchcommunity

for

Search:↓

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Trichoscopy is better than the hair pull test for tracking alopecia areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Minoxidil may help hair regrowth in traction alopecia, but changing hair habits is the main treatment.

A combination of cyclosporine and oral corticosteroid successfully regrew hair in a 19-year-old with alopecia universalis.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Ayurvedic treatment led to complete hair regrowth in a patient with Alopecia Areata.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.